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Brucella is an intracellular pathogen able to persist for long periods of time within the host and establish a chronic
disease. We show that soon after Brucella inoculation in intestinal loops, dendritic cells from ileal Peyer’s patches
become infected and constitute a cell target for this pathogen. In vitro, we found that Brucella replicates within
dendritic cells and hinders their functional activation. In addition, we identified a new Brucella protein Btp1, which
down-modulates maturation of infected dendritic cells by interfering with the TLR2 signaling pathway. These results
show that intracellular Brucella is able to control dendritic cell function, which may have important consequences in
the development of chronic brucellosis.
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Introduction
The immune response to bacterial infection relies on the
combined action of both the innate and adaptive immune
systems. Dendritic cells (DCs) are known as mediators of
pathogen recognition and are strategically located at the
typical sites of bacterial entry and have the ability to migrate
from peripheral tissues to secondary lymphoid organs to
elicit primary T cell responses and initiate immunity.
DCs express several pathogen recognition receptors such as
C-type lectins and Toll-like receptors (TLRs) that recognise
molecular patterns expressed by pathogens and determine
the type of immune response. Microbial stimuli induce
signiﬁcant morphological and biochemical changes, such as
IL-12 secretion and increased surface expression of many co-
stimulatory and MHC class II molecules. This activation of
DCs, known as maturation, is required for efﬁcient T-cell-
priming and pathogen elimination. However, several bacte-
rial pathogens have developed mechanisms to subvert DC
function and evade the immune system. Mycobacterium tuber-
culosis interferes with TLR signalling via the C-type lectin DC-
SIGN, blocking DC maturation and IL-12 production [1]. The
immune response is instead directed towards immune
suppression with secretion of IL-10, which seems to contrib-
ute to the chronic carriage of this pathogen. Similarly,
Bordetella pertussis-infected DCs secrete IL-10 and activate T
regulatory cells that suppress a protective immune response
and enhance colonisation of the lower respiratory tract [2]. In
addition, several studies have shown that while Salmonella
typhimurium induces normal maturation of DCs and secretion
of pro-inﬂammatory cytokines [3,4] it is able to block MHC
class II antigen presentation in bone marrow-derived DCs
[5,6]. Another bacterial pathogen, Francisella tularensis, which
also induces phenotypic maturation of DCs, has been shown
to inhibit secretion of pro-inﬂamatory cytokines such as
TNF-a while eliciting production of immunosuppressive
cytokines that facilitate pulmonary infection [7]. F. tularensis
has also been shown to replicate efﬁciently within DCs [7] in
contrast to many other bacterial pathogens (including
mycobacteria, Bordetella, Salmonella and Legionella pneumophila)
for which DCs seem to restrict their intracellular growth.
Human brucellosis is a zoonotic disease that results from
direct contact with infected animals or ingestion of con-
taminated food products. It is usually presented as a
debilitating febrile illness that can progress into a chronic
disease with severe complications such as infection of the
heart and bones. It has been previously shown that B. abortus
infection in calves using an intestinal loop model occurred
via Peyer’s patches [8]. Several studies using animal models
have established macrophages and placental trophoblasts as
two key targets of Brucella infection [9] but a more recent
study has shown that Brucella can replicate in vitro within
human monocyte-derived DCs [10]. DCs may therefore
constitute an important cellular niche to promote infection.
Brucella virulence is dependent on its ability to survive and
replicate within host cells. Once internalised, Brucella is found
within a compartment, the Brucella-containing vacuole (BCV)
that transiently interacts with early endosomes [11]. However,
BCVs do not fuse with lysosomes and instead fuse with
membrane from the endoplasmic reticulum (ER), to establish
a vacuole suited for replication [11,12]. An important
virulence factor of Brucella is its unconventional lipopolysac-
charide (LPS) that is necessary for entry and early develop-
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important immuno-modulatory activities by forming non-
functional complexes with MHC class II at the cell surface of
macrophages [14]. More recently, the periplasmic Brucella
cyclic b-1,2-glucan, which interacts with lipid domains, has
been implicated in the early biogenesis of BCVs [15]. At later
stages of BCV trafﬁcking, the VirB type IV secretion system
enables interactions with the ER and formation of an ER-
derived compartment suitable for Brucella intracellular
replication [12,16,17]. However, no secreted effector mole-
cules of the VirB type IV secretion system have yet been
identiﬁed.
Although there is increasing knowledge about the virulence
factors that enable Brucella to survive inside host cells, it is still
unclear how Brucella is able to remain hidden from the
immune system and cause chronic disease. The escape from
the lysosomal pathway and fusion with the ER may interfere
with the ability of host cells to mount an efﬁcient immune
response against Brucella. In this study, we used a murine
intestinal loop model of infection and found that intestinal
DCs from the region underlying the follicle associated
epithelium (FAE) of Peyer’s patches were infected by B.
abortus soon after inoculation. To better characterise the
consequences of B. abortus infection on the immune functions
of DCs, we have used murine bone marrow-derived dendritic
cells (BMDCs) as a model system. B. abortus replicates within
BMDCs and inhibits the process of DC maturation, ultimately
leading to a reduction of cytokine secretion and antigen
presentation. We have also identiﬁed a Brucella protein, Btp1,
which contributes to inhibiting maturation of infected DCs in
vitro by targeting the TLR2 signalling pathway, highlighting a
new mechanism used by Brucella to control the immune
response of the host.
Results
B. abortus Infection of Intestinal DCs
We used a mouse intestinal loop model to characterise the
cellular targets of B. abortus by confocal microscopy during
early stages of the infection. One hour after inoculation in a
loop containing at least one Peyer’s patch, B. abortus mainly
penetrated the epithelium through the FAE of Peyer’s
patches and were either associated or internalized by cells
presenting a ‘‘dendritic-like’’ morphology and identiﬁed as
DCs on the basis of their positivity for CD11c (Figure 1). On
more than one hundred cells associated with B. abortus we
observed, 50% were CD11cþ cells, the others being either
FAE cells (30%) or not determined. Few bacteria were also
observed in the lamina propria of adjacent villi (Figure 1).
These were always associated with CD11cþ cells. Thus, in the
mouse model, DCs are a cellular target of B. abortus during
enteric infection.
B. abortus Replicates within ER-derived Vacuoles in Murine
BMDCs
Having established the relevance of DCs in the context of
Brucella infection we used BMDCs as cellular model to
characterise the intracellular fate of Brucella. We ﬁrst analysed
the survival of the wild-type B. abortus 2308 strain in murine
BMDCs by enumerating the colony forming units (CFU) at
different times after infection. We observed an increase in
the number of intracellular bacteria up to 48 h after
inoculation, showing that the wild-type B. abortus is able to
survive within BMDCs (Figure 2A). Equivalent results were
obtained in CD11c-positive cells (Figure 2A, graph on the
right). Intracellular replication was conﬁrmed by microscopic
examination of infected cells. At 2 h after infection cells
contained on average 1.2 6 0.1 bacteria per cell in contrast to
17.7 6 3.4 bacteria per cell at 48h. Although high intracellular
bacterial loads were observed, viability of BMDCs was not
affected up to 48 h after infection (Figure S1). At 24 and 48 h
we found that only a small percentage of infected cells
(approximately 12 and 25%, respectively) contained more
than 10 bacteria, indicative of intracellular replication. This
observation is similar to what was previously described for
murine bone marrow-derived macrophages [12] and HeLa
cells [11]. In agreement with previous reports, we did not
observe replication with the wild-type Salmonella typhimurium
[18]. In the case of a strain lacking the type IV secretion
component virB9, there was a continuous decrease in CFU
numbers, suggesting that this system is necessary for the
establishment of the Brucella replicative niche in DCs.
Surprisingly, in contrast to other cell types [15,19] the cyclic
b-1,2 glucan synthesized by Brucella was not required for
virulence during DC infection since cgs
 mutants replicated as
efﬁciently as the wild-type strain (Figure 2A).
Loss of lysosomal and acquisition of ER markers on BCVs
are hallmarks of Brucella infection. We therefore analysed the
recruitment of lysosomal associated membrane protein 1
(LAMP1) and of the ER-speciﬁc KDEL bearing molecules in
MHC II expressing CD11c-positive DCs by immunoﬂuores-
cence confocal microscopy (Figures 2 and S2). As expected,
virB9
 mutant BCVs retained LAMP1 whereas wild-type BCVs
progressively lost this marker (Figure 2B). At 24 h after
infection only a small percentage of wild-type BCVs
contained LAMP1 in contrast to the virB9
  mutant (Figure
2C). Concomitant to LAMP1 decrease, a signiﬁcant propor-
tion of wild-type BCVs became positive for the ER retention
and retrieval epitope KDEL (50.7 6 3.5%, Figure 2D), albeit
to a lower level than in macrophages [12]. Wild-type BCV
fusion with ER membranes was conﬁrmed through ultra-
structural examination by electron microscopy of infected
DCs. BCVs were often outlined by ribosomes (Figure 2E) and
cytochemical detection of glucose 6-phosphatase activity, an
enzyme mostly found in the ER lumen, revealed that the
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Author Summary
A key determinant for intracellular pathogenic bacteria to induce
infectious diseases is their ability to avoid recognition by the host
immune system. Although most microorganisms internalized by
host cells are efficiently cleared, Brucella behave as a Trojan horse
causing a zoonosis called brucellosis that affects both humans and
animals. Here we show that pathogenic Brucella are able to target
host cell defense mechanisms by controlling the function of the
sentinels of the immune system, the dendritic cells. In particular, the
Brucella TIR-containing protein (Btp1) targets the Toll-like receptor 2
activation pathway, which is a major host response system involved
in bacterial recognition. Btp1 is involved in the inhibition of
dendritic cell maturation. The direct consequence is a control of
inflammatory cytokine secretion and antigen presentation to T
lymphocytes. These bacterial proteins are not specific for Brucella
and have been identified in other pathogens and may be part of a
general virulence mechanism used by several intracellular patho-
gens to induce disease.PLoS Pathogens | www.plospathogens.org February 2008 | Volume 4 | Issue 2 | e21 0003
Brucella Controls DC Immune Responsesmajority of BCVs were positive for this enzymatic activity at
24 h after infection. In cryosections of infected DCs we
observed ER membranes directly fusing with BCVs (Figure 2F,
blue arrows), which were also decorated with an antibody
against the ER resident protein calnexin (Figure 2G). In
addition to the ER cisternae, which were extensively labelled
(data not shown), gold particles were present on the vacuolar
membranes surrounding Brucella and on tubular-like ER
membranes connecting with the vacuoles (blue arrows) as well
as on vesicles in the vicinity of BCVs (red arrow). Together,
these results conﬁrm that Brucella is dependent on its VirB
type IV secretion system to replicate within DCs in an ER-
derived compartment that evades the lysosomal degradative
pathway, similar to what has been observed for other cell
types, in particular within bone marrow-derived macro-
phages [12].
B. abortus Interferes with Phenotypic Maturation of DCs
Most studies have shown that infection of DC is generally
associated with their activation and a mature phenotype. This
phenotype is characterized not solely by the up-regulation of
co-stimulatory and MHC class II molecules at the cell surface,
but also by the intense clustering of multivesicular bodies
(MVB) around the microtubule organizing center (MTOC)
[20], as well as the formation of large cytosolic dendritic cell
aggresome-like induced structures (DALIS), which are made
of defective newly synthesised ubiquitinated proteins [21].
This situation is well illustrated by Salmonella-infected DCs
(Figure 3A), in which MHC class II molecules mostly localize
on the cell surface and MVBs, labelled with LAMP1, are often
tightly concentrated at the MTOC. Surprisingly, most of
Brucella-infected DCs did not show any sign of maturation,
since Brucella-bearing cells rarely displayed lysosomal cluster-
ing or MHC II surface accumulation (Figure 3A). Instead,
MHC II molecules remained mostly intracellular co-localising
with LAMP1 as observed in non-activated DCs. At 24 h after
inoculation, only 14.3 6 0.5% of Brucella-infected DCs (versus
31.9 6 8.3% for Salmonella) displayed a mature phenotype in
terms of MHC II molecules and LAMP1 distribution,
suggesting that Brucella does not promote DC activation.
We then tested if DALIS formation was also impaired in
infected cells. Although the function of DALIS is still unclear,
these structures are easily detectable using the FK2 antibody
that recognises both mono- and polyubiquitinated proteins,
and therefore provide an effective way of monitoring DC
maturation by microscopy. Thus, we compared the kinetics of
DALIS formation in DCs infected with either Brucella or
Salmonella, previously shown to induce normal maturation of
DCs [3,6] (Figure 3B–3D). In the case of Salmonella, formation
of DALIS began after 4 h (as reported with E. coli LPS [21]),
with 90% of infected cells containing large and numerous
DALIS 24 h after infection (Figure 3B and 3C), while only
20% of control cells contained DALIS, probably due to
mechanical or spontaneous maturation. Although signiﬁ-
cantly higher than the control (p ¼ 0.005), only 43% of
Brucella-infected DCs contained DALIS 24 h after infection
and this number remained stable a later time-points (Figure
3C). Furthermore, the average size of Brucella-induced DALIS
was always considerably smaller than that of DALIS formed in
the presence of Salmonella (Figure 3B). These observations
suggest the Brucella replication in DC could be restricting the
maturation process. A signiﬁcantly higher proportion of DCs
infected with virB9
 , a mutant that does not replicate in DCs,
contained DALIS at 24 h after infection (p¼0.006, Figure 3D).
Similar results were obtained when analysing DCs activated
with heat-killed B. abortus (p ¼ 0.018, Figure 3D), consistent
with the hypothesis that B. abortus is actively inhibiting the
maturation of DCs.
The extent of this inhibition was monitored by ﬂow
cytometry of CD11c-positive DCs infected with GFP-express-
ing Brucella or Salmonella, for surface expression of classical
maturation markers (eg CD80, CD86 and MHC molecules).
Analysis of the median of ﬂuorescence (Figure 4A) or the
geometric mean (data not shown) in the CD11c
þGFP
þ
populations showed a consistently lower surface expression
of all co-stimulatory and MHC class II molecules in cells
infected with B. abortus than in Salmonella-infected cells
(Figure 4A and 4B). However, statistical difference between
B. abortus and Salmonella was only observed for CD86
expression (p ¼ 0.011). This is probably due to the fact that
in the case of Brucella-infected DCs two populations were
observed (overlay histograms, Figure 4A and 4B), one with a
moderately increased surface levels in comparison to control
cells and the other with similar levels of expression to
Salmonella-activated DCs. This is in agreement with micro-
scopy observations where a high proportion of MHC class II
molecules remained intracellular in Brucella-infected cells
(Figure 2A). Surprisingly, we did not detect any signiﬁcant
difference in the surface expression of MHC class I molecules
in cells infected by the two pathogens (Figure 4B), thus
suggesting the expression of MHC class I molecules is
controlled differently than MHC class II and co-stimulatory
molecules. Together, these data conﬁrm that maturation of
Brucella-infected DCs is impaired.
In addition, we have found that Brucella can only establish
its intracellular replicative niche in immature DCs (Figure
S3). When E. coli LPS was added to cells (to induce
maturation) early after infection (0.5 to 6 h), there was a
signiﬁcant inhibition of bacterial growth (p , 0.001, Figure
Figure 1. Infection of DCs from the Sub-epithelial Dome Region of Ileal Peyer’s Patches with B. abortus
(A) Cellular organization of a Peyer’s patch dome. DCs are enriched in the Sub-Epithelial Dome (SED) underlying the Follicle-Associated Epithelium (FAE)
and in the Inter-Follicular Region (IFR) in vicinity of the High Endothelial Venules (HEV).
(B) Sixty minutes after intestinal loop infection, B. abortus (red) adhered on both villi epithelium (VE) and FAE surfaces. However, only few of them were
observed in villi lamina propria (LP). These were always observed in association with CD11cþcells (green, arrowhead). Most B. abortus bacteria reached
the under-epithelial compartment of the gut through the FAE. Some of these were observed inside CD11cþcells (arrows and insert), while others were
in close association with CD11cþ dendrites (arrowheads).
(C) High magnification field of a Peyer’s patch infected with GFP-expressing Brucella. Images in the first and the second row, corresponding to area
depicted by the squared box in (A), show either Brucella (GFP in green and LPS in red) internalized by CD11þcells (blue, representative of 29 out of 118
B. abortus-associated cells) or the close association of one B. abortus expressing GFP with dendrites from a CD11cþcell of the SED region (representative
of 30 out of 118 B. abortus-associated cells), respectively. The image in the last row shows one of the rare B. abortus-associated cells (all CD11cþ) from
the villus (GC, goblet cells). Close association or internalization was always confirmed by the combined xy, xz, and/or yz views as shown in inserts. Bars,
20 lm.
doi:10.1371/journal.ppat.0040021.g001
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Brucella Controls DC Immune ResponsesS3). However, bacterial CFU counts did not decrease when
LPS was added at 12 h after infection, suggesting that Brucella
survival is not affected by DC maturation at a time point that
corresponds to its arrival in the ER [11,12]. In contrast,
addition of E. coli LPS had no signiﬁcant effect on the
intracellular survival of Salmonella in DCs (data not shown),
thus further underlining the need for Brucella to avoid DC
maturation.
Brucella Interferes with DC Function
DCs infected with B. abortus do not achieve full maturation.
We therefore investigated the consequences of Brucella
infection on the ability of DCs to secrete cytokines, by
analysing the supernatants of infected cells. Levels of TNF-a,
IL-12 (p40/p70), IL-6 and IFN-b were consistently and
considerably lower in supernatants from Brucella- than from
Salmonella-infected cells (Figure 5A). This effect was observed
at 24 h as well as at 48 h after infection (data not shown)
suggesting that Brucella infection inhibits the secretion of
immuno-stimulating cytokines.
Intracellular IL-12 (p40/p70) expression was further ana-
lysed by ﬂow cytometry. DCs incubated with either media
alone or infected with GFP-expressing Brucella or Salmonella
were labelled at 4 and 24 h post-inoculation with anti-CD11c
and IL-12 (p40/p70) antibodies. Analysis of IL-12 expression
was carried out on CD11c
þ cells (Figure 5B). IL-12 expression
in Salmonella-infected DCs peaked after 4 h, similarly to what
observed with E. coli LPS (data not shown), whereas in Brucella-
infected DCs, IL-12 expression was only detected after 24 h
(Figure 5B). Similar results were obtained when analysing
GFP-positive populations for each pathogen (data not
shown).
These results indicate that Brucella,l i k eFrancisella, is
capable of interfering with the ability of DCs to secrete
cytokines. Interestingly, Brucella also reduced the capacity of
DCs to present exogenous ovalbumin to speciﬁc T cells in the
context of MHC class I and class II (Figure 5C) suggesting that
Brucella is generally down-modulating the immuno-stimula-
tory properties of maturing DCs both at the cytokine
production level and also at the antigen processing and
presentation level.
Identification of a Brucella Protein Involved in the Control
of DC Maturation
The Brucella genome was searched for candidate proteins
responsible for interfering with DC maturation. We identi-
Figure 2. Survival and Replication of B. abortus in DCs
(A) BMDCs infected with wild-type B. abortus, cgs
 mutant, virB9
 mutant
or the wild-type S. typhimurium were lysed and intracellular CFUs
enumerated at different times after inoculation. Graph on the right
corresponds to bacterial CFU counts performed in CD11c-positive cells
infected with either wild-type B. abortus or virB9
  mutant. Statistical
significance was obtained at 24 and 48 h between wild-type and the virB
mutant (p , 0.002) and also between wild-type Brucella and Salmonella
at 24 h (p ¼ 0.047) and 48 h (p , 0.002).
(B) Quantification of the percentage of wild-type or virB9
  mutant BCVs
that contain LAMP1 by confocal immunofluorescence microscopy. The
difference between wild-type and the virB mutant were always statisti-
cally significant (p ¼ 0.045 at 30 min and 4 h; p , 0.002 for other
timepoints).
(C) Representative confocal images of DCs infected for 24 h with wild-
type B. abortus or virB9
 mutant expressing GFP, labelled with antibodies
against MHC II (blue) and LAMP1 (red).
(D) Confocal image of DCs infected for 24 h with wild-type B. abortus
expressing GFP, labelled with antibodies against MHC II (blue) and KDEL
(red). Samples were also processed for conventional electron microscopy
(E), cytochemistry for glucose 6 phosphatase detection (F) or immuno-
gold labelling with an anti-calnexin antibody (G). Bars: 5 lm (C and D);
0.5 lm (F and G). For (A) and (B) data are means 6 standard errors of
four independent experiments.
doi:10.1371/journal.ppat.0040021.g002
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Brucella Controls DC Immune ResponsesFigure 3. B. abortus Interferes with DC Maturation
DCs were infected with different B. abortus strains or with Salmonella and labelled with the anti-MHC II and anti-LAMP1 antibodies (A) or FK2 antibody
(B) to detect MVBs or DALIS, respectively.
(C) Comparison between the percentages of DCs infected with either wild-type B. abortus (black bars) or S. typhimurium (white bars) that contain DALIS.
The negative control (grey bars) corresponds to mock-infected DCs with DALIS. The difference between Brucella and Salmonella infected cells at 24 h is
statistically significant, p , 0.0001.
(D) Quantification of the percentage of DCs with DALIS at 24 h after incubation with media (negative), wild-type B. abortus (wt), virB9
  mutant or heat-
killed B. abortus (HK). The differences between wild-type wt and either virB9
  or HK are statistically significant (p¼0.0059 and p¼0.018, respectively).
For (C) and (D) data represent means 6 standard errors of at least three independent experiments. Bars: 10 lm (A); 5 lm (B).
doi:10.1371/journal.ppat.0040021.g003
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Brucella Controls DC Immune ResponsesFigure 4. B. abortus-infected DCs Have Reduced Expression of Co-stimulatory Molecules
(A and B) DCs were either incubated with media only (blue line) or infected with B. abortus (shaded grey) or S. typhimurium (red line) expressing GFP for
24 h. DCs were labelled with anti-CD11c conjugated with APC and anti-CD40, CD80, CD86, MHC II, and MHCI antibodies conjugated with PE.
Representative histograms and values of median of the PE fluorescence (FL2) correspond to CD11c
þcells for the negative and CD11c
þGFP
þcells for the
Brucella and Salmonella infected cells. Values of the median fluorescence correspond to four independent experiments.
doi:10.1371/journal.ppat.0040021.g004
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Brucella Controls DC Immune Responsesﬁed one candidate protein: BAB1_0279 (YP_413753), a 250-
amino acid protein containing a c-terminal 130-amino acid
domain with signiﬁcant sequence similarity to Toll/interleu-
kin 1 receptor (TIR) domain family (smart00255, e-value of
4E
 11). Sequence comparison with the human TIR containing
proteins TLR2, TLR4, SIGIRR, MyD88 and IL-1R acP
indicated similarity particularly in box 1, the signature
sequence of the TLR family, and in box 2 which is reported
to be important for signaling [22] (Figure 6A). This Brucella
protein, which we have designated Btp1 (Brucella-Tir-Protein
1), is also homologous to TlpA, a Salmonella effector that
interferes with TLR signaling in vitro [23]. The btp1 gene is
located in a 20-Kb genomic island on chromosome I and is
present in B. abortus and B. melitensis but absent from B. suis.
Interestingly, the island appears to have been acquired
recently via a phage-mediated integration event [24].
In order to test if this protein could be responsible for
Brucella immunomodulatory properties, we infected DCs with
Brucella knock-out mutants of btp1. We ﬁrst observed that the
mutant strain replicated as efﬁciently as the wild type Brucella
in DCs (Figure 6B and 6C). Next, the degree of DC activation
after infection with this mutant was monitored by ﬂow
cytometry and microscopy. Interestingly, the level of surface
expression of MHC II and CD80 were augmented in DCs
infected with the btp1 mutant when compared the wild-type.
However, CD40 and CD86 were not signiﬁcantly affected
(Figure S4). In contrast, a signiﬁcantly higher percentage of
DCs infected with btp1
  contained DALIS at 24 h after
infection (p , 0.001), in comparison to DCs infected with the
wild-type strain (Figure 6D). Although, btp1
  did not induce
formation of DALIS to the same level than Salmonella (Figure
3B), it was equivalent to heat-killed B. abortus (HKB, Figure
6D) and could be partially complemented by expressing btp1
(btp1
  pbtp1, Figure 6D). Therefore, the ability of Brucella to
inhibit formation of DALIS is dependent on Btp1. In order to
exclude a potential role of Btp1 on LPS immunostimulation
properties, LPS extracted from Brucella wt and the Btp1
mutant were tested on DCs. Neither LPS from wt or btp1
mutant was found to promote DC activation (Figure S5A and
S5B). Therefore, the increase of maturation in infected cells
with the btp1 mutant is not due to modiﬁcation of its LPS. In
addition, an increase in the level of expression and secretion
of TNF-a and to a lesser extent IL-12 (Figure 6E and 6F) was
observed at both 24 and 48 h after infection, consistent with a
role for Btp1 in controlling DC function. However, the IL-12
levels were lower than the levels obtained with heat-killed B.
abortus suggesting that other Brucella factors might block DC
activation. Complementation of the mutant phenotype was
also attained for both TNF-a and IL-12 (Figure S5C).
Brucella Btp1 Protein Modulates TLR Signalling
TLR signal transduction pathways are essential for the
induction of DC maturation and secretion of pro-inﬂamma-
tory cytokines. The most important TLRs in the context of a
bacterial infection are TLR2, TLR4, TLR5 and TLR9 that
recognize lipoproteins, LPS, ﬂagellin and CpG DNA, respec-
tively. However, recent work showed that DCs poorly respond
to ﬂagellin due to limited TLR5 expression in these cells [25]
so we therefore excluded this pathway. To determine if Btp1
was interfering with a speciﬁc TLR in the context of an
infection we used DALIS formation as a read-out, since the
increased number of DCs with DALIS was the clearest
phenotype for the btp1 mutant when compared to wild-type
Brucella. DCs from different TLR knockout mice were
infected with Brucella wild-type or the btp1 mutant and
analysed by confocal immunoﬂuorescence microscopy. We
observed that DCs from wt mice infected with btp1
 
contained a very high number of DALIS, contrasting with
infected TLR2 /  DCs (Figure 7A), a phenotype reminiscent
of DCs treated with the TLR2 ligand PAM. This difference
was not noticeable in other TLR knockout mice used. Indeed,
quantiﬁcation of the number of infected DCs containing
DALIS conﬁrmed that DCs infected with the btp1 mutant
showed increased DALIS formation in wild-type, TRIF / ,
TLR4 / , TLR7 / and TLR9 / DCs but not in TLR2 / and
to a lesser extent in MyD88 / DCs (Figure 7B). These results
suggest that inhibition of DC maturation by Btp1 is at least in
part dependent on the TLR2 pathway. Appropriate ligands
were used as positive controls for the assay (Figure S6). In
addition, we found that DC maturation induced by heat-
killed Brucella, as measured by DALIS formation, was also
dependent on TLR2 (Figure S7). This result is consistent with
previous reports showing that TNF-a secretion induced by
heat-killed Brucella in DCs is partially dependent on TLR2
and MyD88 pathways [26]. We then investigated if the ability
of Brucella to reduce DC maturation was dependent on the
TLR2 pathway. DCs were infected with wild-type B. abortus for
24 h to allow establishment of a replication niche and then
incubated with either LPS or PAM for a further 24 h. We
found that DCs infected with wild-type Brucella and treated
with E. coli LPS were very activated and contained very large
DALIS, similar to what has been observed in LPS-treated
cells. In contrast, infected cells treated with PAM contained
only small DALIS similar to untreated infected cells.
However, non-infected cells treated with PAM contained
Figure 5. B. abortus Interferes with DC Function
(A) and (B) B. abortus blocks secretion of pro-inflammatory cytokines.
(A) Supernatants were obtained at 24 h from DCs inoculated with either media (negative), B. abortus, S. typhimurium, or heat-killed B. abortus (HKB) and
the levels of cytokines were determined by ELISA. Values correspond to means 6 standard errors of at least three independent experiments. A clear
statistical difference was observed between Brucella and Salmonella for TNF (p ¼0.014) and IL12 (p¼0.0098) and to a lesser extent for IL6 (p¼0.041)
and IFNß (p ¼ 0.040).
(B) DCs were infected for 4 or 24 h with either media (negative), B. abortus or S. typhimurium constitutively expressing GFP. DCs were then treated for 1
h with brefeldin A, permeabilised and labelled with anti-CD11c and anti-IL12 (p40/p70) conjugated with APC and PE, respectively. Representative dot
blots are shown for CD11c
þ populations.
(C) B. abortus reduces the capability of DCs to induce T cell proliferation. DCs were infected with wild-type B. abortus and the model antigen ovabulmin
(OVA) was added after 30 min at a final concentration of 50 lg/ml. Cells were stimulated with OVA for 2 h and then washed to remove the antigen.
Splenic CD4
þ T cells prepared from OTI and OTII transgenic mice were then added at a 1:1 ratio and co-cultured for 48 h. IL-2 production in culture
supernatants was measured by
3H-thymidine incorporation on the IL-2-dependent CTLL-2 cell line. Data are the means 6 standard errors from
triplicates of a representative experiment. A small statistical difference was observed between Ova and OvaþBrucella for both OT1 (p¼0.035) and OT2
(p ¼ 0.045).
doi:10.1371/journal.ppat.0040021.g005
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Brucella Controls DC Immune Responseslarge and numerous DALIS (Figure S8). These results conﬁrm
that Brucella is able to control TLR2-dependent DC matura-
tion.
To determine if Btp1 had the ability to speciﬁcally block
TLR2 signalling we expressed increasing amounts of myc-
tagged Btp1 in HEK293T cells along with a constant amount
of either TLR2 or TLR9 (as a negative control) and a
luciferase NF-jB reporter plasmid. We then analysed lucifer-
Figure 6. Btp1 Reduces DC Maturation
(A) Identification of Btp1 as bacterial member of TLR/IL-1R (TIR) family. Comparison of the predicted amino acid sequences of Btp1 with the human
members of the TIR family: TLR2, TLR4, Single Immunoglobulin IL1-R related molecule (SIGIRR), Myeloid Differentiation protein 88 (MyD88), and IL-1
Receptor accessory protein (IL-1R acP). Significant sequence similarity is observed in Box 1 and Box 2, which are important signatures of all TIR domain
proteins. The alignment was constructed with T-Coffee::advanced server from EMBnet (http://www.ch.embnet.org/). The color scheme is representedi n
the figure and is indicative of the reliability of the alignment, with red corresponding to highest probability of correct alignment. DCs infected with wild-
type B. abortus or btp1
  were either (B) fixed at 24 h and immunolabelled for MHC II (red) and Brucella (green) or (C) cells were lysed at 2, 24, and 48 h
and CFU enumerated.
(D) Quantification of the percentage of DCs containing DALIS. DCs were incubated for 24 h with media (negative), heat-killed B. abortus (HKB), wild-type
B. abortus (wt), btp1
  mutant strain or a btp1
  mutant with a plasmid containing btp1 (btp1
 pbtp1). There is a very significant statistical difference
between the wt and btp1
  (p ¼ 0.0002) but only a small difference between btp1
  and btp1
 pbtp1 (p ¼ 0.05).
(E and F) Analysis of TNF-a and IL-12 (p40/p70) secretion measured by ELISA from the supernatant of DCs 24 and 48 h after inoculation. All the results
correspond to the means 6 standard errors of four independent experiments. A statistical difference was observed between wild-type Brucella and btp1
mutant at 24 h for TNF (p ¼ 0.029) and IL12 (p ¼ 0.045).
doi:10.1371/journal.ppat.0040021.g006
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Salmonella effector protein , myc-PipB2, was also included as a
negative control as it is known to affect kinesin recruitment
rather than cell signalling [27]. We found that Btp1 efﬁciently
inhibited TLR2 signalling, in a dose dependent manner but
not TLR9 (Figure 7C).
In conclusion, Btp1 is able to interfere with the TLR2 to
reduce the progression of maturation in infected DCs.
Discussion
Brucella enteric infection has been found to occur in calves’
Peyer’s patches [8]. Using a murine intestinal loop model, we
found that after penetrating the epithelium, B. abortus
localized in DCs just below the FAE of Peyer’s patches.
Interestingly, a few bacteria were also observed in the inter-
follicular region of Peyer’s patches or in the lamina propria
of adjacent villi, were they were always associated with DCs.
Unlike most pathogens, Brucella was able to establish a
replication niche within DCs cultured in vitro in a very
similar manner to what has been described in macrophages
and non-phagocytic cells. DCs therefore constitute a poten-
tially important cellular target for Brucella infection.
Interestingly, we have found that although the VirB type IV
secretion system is required for virulence in DCs, the Brucella
cyclic b-1,2-glucan is dispensable for early events of BCV
biogenesis. The Brucella cyclic b-1,2-glucan, which modulates
lipid microdomain organisation [15], is essential for prevent-
ing fusion between BCVs and lysosomes in macrophages and
non-phagocytic cells. It is possible that within DCs early BCVs
have a different membrane composition than in macro-
phages. In the case of human monocyte-derived DCs, Brucella
strongly induces the formation of veils on the plasma
membrane during internalisation, a phenomenon not ob-
served in macrophages [10]. Alternatively, the proteolytic and
bactericide activity of DC endosomes and phagosomes, which
has been shown to be considerably limited when compared to
macrophages [28,29], potentially eliminates the need for
cyclic b-1,2-glucan during infection. Further work will be
required to characterise in detail the molecular mechanisms
of Brucella internalisation by DCs.
An important aspect of Brucella pathogenesis is its ability to
evade the immune system and persist within the host. In vitro
Figure 7. B. abortus Protein Btp1 Modulates TLR Signaling
(A) Representative images obtained by immunofluorescence microscopy
of DCs from wild-type mice or TLR2 knockout mice labelled for MHC II
(blue), DALIS (red), and in the case of lower panel also labelled for
Brucella (green). Cell were either stimulated with PAM (500 ng/ll, upper
panel) or infected with the Brucella wild-type and btp1
  mutant strains
(lower panel).
(B) DCs obtained from wild-type mice or different knockout mice were
infected for 24 h with either B. abortus wild-type or btp1
  mutant strain.
The percentage of DALIS in infected cells was then quantified and the
data represent means 6 standard errors of four independent experi-
ments. The average value for the wild-type Brucella is indicated with a
red line. For btp1
 we observed a statistical difference (*) between the wt
and TLR2 /  DCs (p ¼ 0.031).
(C) HEK293 cells were transiently transfected for 24 h with three vectors:
a luciferase reporter vector and either empty vector, myc-Btp1 or myc-
PipB2 along with either TLR2 (upper panel) or TLR9 (lower panel). The
amounts of Btp plasmids are indicated in the graph (ng). Data represent
the means 6 standard errors of relative luciferase activity obtained from
triplicates of a representative experiment. In the case of TLR2, cells were
stimulated with PAM (500 ng/ll) and for TLR9 with CpG (1 lM) for 6 h
before measuring the luciferase activity.
doi:10.1371/journal.ppat.0040021.g007
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unnoticed by host cells, notably by having an atypical LPS
[30], which is several hundred times less toxic than Salmonella
or E. coli LPS. Although, shown to signal through the TLR4
pathway, Brucella LPS is not a potent inducer of pro-
inﬂammatory cytokines and anti-microbial proteins such as
the IFN-c inducible p-47 GTPases [31]. DCs treated with up to
10 lg/ml of puriﬁed Brucella LPS, did not induce phenotypic
maturation nor signiﬁcant secretion of pro-inﬂammatory
cytokines (Figure S4A and data not shown). Conversely, DCs
incubated with heat-killed B. abortus showed signiﬁcant
maturation indicating that host cells can detect Brucella
pathogen associated molecular patterns (PAMPs), other than
LPS. A recent study has shown that a lumazine synthase from
Brucella can activate DCs via TLR4 [32]. In addition, heat-
killed Brucella can induce TLR9 and promote Th1-mediated
responses in both DCs and macrophages [33] probably after
bacterial degradation in lysosomes.
Immunity against Brucella requires cell-mediated mecha-
nisms that result in the production of cytokines such as IL-12
and IFN-c. In this study, we have shown that Brucella inhibits
or delays the process of DC maturation to establish a
replicative niche, which results in reduced cytokine secretion
and disabled antigen presentation. It is likely that impaire-
ment of DC function and cytokine secretion by Brucella
favours infection and/or promotes the establishment of the
chronic phase of the disease. Although, we did not detect any
signiﬁcant secretion of IL-10 in infected DCs it is possible
that, by preventing their full activation, Brucella uses the
tolerogenic properties of DCs to subvert the immune
response. There is growing evidence that induction of
tolerance is not restricted to immature DCs. Recent studies
have shown that migrating DCs, which are mature or in the
process of maturing (bearing considerable surface expression
of MHC class II molecules) are capable of inducing tolerance
[34–36]. Brucella-infected DCs, which show an intermediate
level of maturation could therefore contribute to tolerance
induction in tissues and establishment of chronic infection.
Consistent with this hypothesis, reduction of IL-10 levels in
mice has been shown to improve host resistance to Brucella
infection [37]. In addition, a new Brucella virulence protein
(PrpA) was recently identiﬁed as a potent B-cell mitogen and
IL-10 inducer [38]. Indeed, this protein is necessary for the
early immuno-supression observed in Brucella-infected mice
and the establishment of chronic disease. Brucellosis develop-
ment is a complex process that involves many virulence
factors some of them, such as the VirB type IV secretion
system, are required for virulence in different cell types,
whereas others may function in speciﬁc cell types, such as the
Brucella cyclic b-1,2-glucan in macrophages and PrpA in B-
cells.
A recent study has shown that Brucella-infected human
myeloid DCs do not mature extensively and instead secrete
low levels of IL-12 and TNF-a and have an impaired capacity
to present antigens to naı ¨ve T cells [39]. These results are
consistent with our data in murine DCs. However, this study
implicates the Brucella outer membrane protein Omp25 and
the two-component regulatory system BvrRS in the control of
DC maturation through blockage of TNF-a secretion. This is
not surprising as both these mutants have signiﬁcant
modiﬁcations of their outer membrane and LPS structure,
which are an essential feature of Brucella virulence enabling
bacteria to escape pathogen recognition [40,41]. Therefore
the effects observed are more likely to be pleiotropic than
speciﬁc to DC maturation. Furthermore, in the case of the
bvrR mutant, which they show induces higher maturation
than the omp25 mutant, the increased maturation is most
likely due to its degradation in lysosomal compartments (the
equivalent results can be obtained with heat-killed Brucella)
since this mutant was previously shown to be unable to
replicate within human DCs by the same group [10].
In this study, we have identiﬁed a new Brucella protein,
Btp1, which contributes to modulation of TLR signalling
within host cells. A mutant lacking this protein showed
increased levels of DALIS formation and also an increase in
secretion of pro-inﬂammatory cytokines. However, the level
of surface expression of some co-stimulatory molecules was
not signiﬁcantly increased in cells infected with the mutant
strain. Thus the existence of other bacterial molecules,
capable of further inhibiting the antigen presentation
capability of DCs, is highly probable and additional studies
are required to identify and characterize these putative new
factors.
By ectopically expressing Btp1, we found that it can inhibit
TLR signalling, particularly TLR2, in a manner consistent
with observations in DCs obtained from different knock-out
mice infected with the btp1 mutant strain. Interestingly, we
did not observe any inhibition of human TLR2 when using
the same concentrations of Btp1. It is possible that higher
amounts of Btp1 are required to block human TLR2 in this
system or it may be that Btp1 speciﬁcally recognizes the
mouse TLR2 Tir domain. Further work is now required to
identify the cellular target of Btp1 and to analyse its role
during infection in vivo. Previous studies have highlighted the
importance of TLR signalling in the control of Brucella
infection, namely the role of the MyD88 adaptor protein in
the clearance of the S19 Brucella vaccine strain in macro-
phages at late stages of the infection [42]. It is interesting that
Brucella produces at least one protein that can act as negative
regulator of TLR signalling, which constitutes an essential
link between the innate and adaptive immune systems. Along
with the Salmonella TIR-containing protein TlpA, they may
constitute a novel class of intracellular bacterial virulence
factors that interfere with TLR signalling and control speciﬁc
steps of the host immune response. We hypothesize that Btp1
is secreted into the host cytosol were it interacts with either
the TLR2 directly and/or with its adaptor proteins resulting
in reduction of TLR2 signalling.
In the case of Salmonella, TlpA is required for virulence in
macrophages and in the mouse model of infection. This is not
the case for Btp1, since a btp1 mutant is not signiﬁcantly
attenuated in the mouse model of brucellosis (Marchesini,
Comerci and Ugalde, unpublished results). Interestingly,
Salmonella infection results in phenotypic activation of DCs
and high secretion of pro-inﬂammatory cytokines probably
due to its LPS (since addition of Salmonella LPS at 100 ng/ml to
DCs results in DC activation; data not shown). Nonetheless,
live Salmonella is able to restrict MHC class II-dependent
antigen presentation [6], however no study has yet been
carried out with the tlpA mutant in this context. It is possible
that the Tir-containing protein TlpA is involved in the
control of DC function but no mechanism has yet been
proposed and it remains unclear how Salmonella interferes
with antigen presentation in DCs. When comparing Salmonella
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pathogens cause very distinct diseases in susceptible mice; S.
typhimurium infection is characterised by fast systemic spread
of the bacteria whereas B. abortus establishes a chronic-like
non-fatal disease. It is therefore likely that DCs play a very
distinct role in the pathogenesis of these two bacteria and
that these pathogens have developed speciﬁc mechanisms to
control the immune response. For example, in the case of
Salmonella, activation of DCs does not affect its intracellular
survival (data not shown) whereas Brucella cannot reach its
ER-derived replication niche in fully matured DCs, which
impact on its survival. In the case of Brucella, infected DCs
remain in an intermediate maturation stage. Although its
atypical LPS enables bacteria to remain less noticeable by the
host, it is interesting that Brucella expresses at least one
protein that interferes to a certain level with DC maturation
and particularly with secretion of pro-inﬂammatory cyto-
kines by DCs. Therefore, it is possible that Btp1 contributes
to the establishment of chronic brucellosis by controlling in
the host immune response within speciﬁc tissues. Overall,
Brucella infection of DCs may therefore be required to control
the anti-bacterial immune response, in addition to providing
a productive replication niche. Alternatively, the migration
properties of DCs could facilitate infection spreading, as
suggested by the rapid interaction of DCs with FAE
penetrating Brucella.
Materials and Methods
Bacterial strains. The bacterial strains used in this study were S.
enterica serovar Typhimurium strain 12023, smooth virulent B. abortus
strain 2308 [11] and the isogenic mutants virB9
  [43], cgs
  BvI129 [15]
and btp1
  (this study, see bellow). In the case of Brucella, green
ﬂuorescent protein (GFP)-expressing derivatives contain a
pBBR1MCS-2 derivative expressing the gfp-mut3 gene under the
control of the lack promoter. The plasmid pVFP25.1 carrying the
gfp-mut3 under the control of a constitutive promoter was used for
Salmonella.Brucellastrainsweregrownintrypticsoybroth(TSB;Sigma-
Aldrich) and Salmonella in Luria Bertani (LB) medium. For infection,
we inoculated 2 ml of media for 16 h at 37 8C up to an optical density
(OD600nm) of approximately 2.0 [12]. Salmonella strains were cultured
16 h at 37 8C with aeration to obtain stationary phase cultures.
Construction of btp1 mutant. A PCR product of 1.257 Kbp
containing the btp1 gene (BAB1_0279) was ampliﬁed using primers
59-caaaactctttcccgcatgcga-39 and 59-tcagataagggaatgcagttct-39 and
ligated to pGem-T-Easy vector (Promega) to generate pGem-T-btp1.
The plasmid was linearized with EcoRV. Linearized pGem-T-btp1 was
ligated to a 0.7 Kpb SmaI fragment containing a gentamicin resistance
cassette to generate pGem-T-btp1::Gm
r. Plasmids were electroporated
into B. abortus S2308 where they are incapable of autonomous
replication. Homologous recombination events were selected using
gentamicin and carbenicillin sensitivity. PCR analyses showed that
the btp1 wild-type gene was replaced by the disrupted one. The
mutant strain obtained was called B. abortus btp1::Gm
r (btp1
 ).
Construction of the btp1 complemented strain. A 1.257 Kpb EcoRI
fragment containing the btp1 gene was excised from pGem-Tbtp1 and
ligated to the EcoRI site of pBBR1-MCS4 [44]. The resulting plasmid
was conjugated into btp1 mutant strain by biparental mating.
Intestinal loop model of infection. C57/BL/6 and BALB/c mice were
starved 24h before anaesthesia. After a small incision through the
abdominal wall was done, a loop starting from the ileoocaecal
junction and containing 2 to 3 Peyer’s patches was formed taking care
to maintain blood supply. Before closing the loop, 200lLo fa1 0
8
CFU/mL culture of B. abortus expressing GFP was injected. The
intestine was then returned to the abdominal cavity for one hour
before the mice were killed and the intestinal loops were removed,
opened ﬂat and washed extensively with PBS. Peyer’s patches were
then ﬁxed with 3.2% paraformaldehyde for 60 minutes, rinsed in
PBS, infused overnight in 35% sucrose and frozen in OCT
compound. Immunoﬂuorescence labelling was performed on 8 to
10 lm thick cryostat tissue sections overnight at 48C using hamster
anti CD11c (N418) and rabbit anti Brucella abortus LPS followed by
incubation with goat anti-rabbit Alexa Fluor 546 and goat anti-
hamster Cy5 for 1h at room temperature.
Bacterial infection and replication assays. BMDCs were prepared
from 7–8 week-old female C57BL/6 mice or TLR2 /  [45], TLR4 / 
[46], MyD88 /  [47], TLR9 /  [48], TRIF /  [49], TLR7 /  [50]
knockout mice, as previously described [51]. Infections were
performed at a multiplicity of infection of 50:1 for ﬂow cytometry
experiments and 20:1 for all remaining experiments. Bacteria were
centrifuged onto BMDCs at 400 g for 10 min at 4 8C and then
incubated for 30 min at 37 8C with 5% CO2 atmosphere. Cells were
gently washed twice with medium and then incubated for 1 h in
medium supplemented with 100 lg/ml streptomycin to kill extrac-
ellular bacteria (or gentamicin for Salmonella). Thereafter, the
antibiotic concentration was decreased to 20 lg/ml. Control samples
were always performed by incubating cells with media only and
following the exact same procedure for infection. To monitor
bacterial intracellular survival, infected cells were lysed with 0.1%
Triton X-100 in H2O and serial dilutions plated onto TSB agar to
enumerated CFUs. When stated cells were previously selected based
on CD11c-labeling using CD11c MicroBeads (MACS, Miltenyi Biotec)
following the manufacture’s instructions.
Antibodies and reagents. The primary antibodies used for
immunoﬂuorescence microscopy were: cow anti-B. abortus polyclonal
antibody; hamster anti-CD11c (N418; Biolegend); afﬁnity puriﬁed
rabbit Rivoli antibody against murine I-A [20]; rat anti-mouse LAMP1
ID4B (Developmental Studies Hybridoma Bank, National Institute of
Child Health and Human Development, University of Iowa); mouse
antibody FK2 (Biomol); mouse anti-KDEL (Stressgen). Monoclonal
anti-calnexin antibody was kindly provided by Dr. D. Williams
(University of Toronto). For ﬂow cytometry allophycocyanin con-
jugated-anti-CD11c antibody (HL3) was used in all experiments along
with either phycoerythrin-conjugated CD40, CD80, CD86, IA-IE
(MHC class II) or H2-2Kb (MHC class I) all from Pharmingen.
Appropriate isotype antibodies were used as controls (data not
shown). For intracellular labelling of IL12 the phycoerythrin-
conjugated IL-12 (p40/p70) monoclonal from Pharmingen was used.
The following TLR ligands from Invivogen were used: ODN1826,
Poly(I:C), Pam2CSK4 and E. coli K12 LPS.
Immunoﬂuorescence microscopy and ﬂow cytometry. Cells were
ﬁxed in 3% paraformaldehyde, pH 7.4, at 37 8C for 15 min and then
processed for immunoﬂuorescence labelling as previously described
[11]. Samples were either examined on a Leica DMRBE epiﬂuor-
escence microscope or a Zeiss LSM 510 laser scanning confocal
microscope for image acquisition. Images of 102431024 pixels were
then assembled using Adobe Photoshop 7.0. In all experiments we
used an antibody against a conserved cytoplasmic epitope found on
MHC-II I-A ß subunits since it strongly labels BMDCs [20] while no
signiﬁcant labelling was detected in bone marrow-derived macro-
phages (Figure S2). All BMDCs signiﬁcantly expressing MHC II were
also labelled with an anti-CD11c antibody conﬁrming that they are
indeed DCs (Figure S2). Quantiﬁcation was always done by counting
at least 100 cells in 4 independent experiments, for a total of at least
400 host cells analysed.
For ﬂow cytometry, infected DCs were collected and stained
immediately before ﬁxation. Isotype controls were included as well as
DCs infected with non-gfp B. abortus as control for autoﬂuorescence.
Cells were always gated on CD11c for analysis and at least 100,000
events were collected to obtained a minimum of 10,000 CD11c-
positive and GFP-positive events for analysis. A FACScalibur
cytometer (Becton Dickinson) was used and data was analysed using
FlowJo software (Tree Star).
Electron microscopy. The detection of glucose-6-phosphatase
activity was performed by electron microscopy cytochemistry as
previously described [52] with minor modiﬁcations. Cells were pre-
ﬁxed in 1.25% (vol/vol) gluteraldehyde in 0.1 M Pipes, pH 7.0,
containing 5% (wt/vol) sucrose for 30 min on ice, washed three times
for 3 min in 0.1 M Pipes, pH 7.0, containing 10% (wt/vol) sucrose and
then brieﬂy in 0.08 M Tris-maleate buffer, pH 6.5. Cells were
incubated in 0.06 M glucose-6-phosphate (Sigma-Aldrich), 0.1% lead
nitrate (wt/vol) in 0.08 M Tris-maleate buffer, pH 6.5 for 2 h at 37 8C.
After 3 washes in 0.08 M Tris-maleate buffer and 3 washes in 0.1 M
cacodylate buffer, pH 7.2, containing 0.1 M sucrose, 5 mM CaCl2 and
5 mM MgCl2, cells were post-ﬁxed in 1.25% (vol/vol) gluteraldehyde in
the same buffer for 1 h at 4 8C, and the, with 1% OsO4 in the same
buffer devoid of sucrose for 1 h at room temperature. Samples were
processed as previously described [52].
For immunoelectron microscopy samples were ﬁxed in 4%
paraformaldehyde in 0.1 M cacodylate buffer, pH 7.2, containing
0.1 M sucrose, 5 mM CaCl2 and 5 mM MgCl2, for 1 h at room
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overnight at 4 8C. Cells were scraped, pelleted, and embedded in 10%
bovine skin gelatin in phosphate Sorensen 0.1 M. Fragments of the
pellet were inﬁltrated overnight with 2.3 M sucrose in PBS at 4 8C,
mounted on aluminium studs and frozen in liquid nitrogen.
Sectioning was done at  110 8C in an Ultracut cryo-microtome
(Leica). The 60 nm thick sections were collected in 1:1 mixture of 2.3
M sucrose and 2% methyl cellulose, transferred onto Formvar-
carbon-coated nickel grids and incubated for 2 min with PBS-glycine
50 mM and then for 20 min with PBS-1% BSA. Sections were then
incubated for 50 min with primary antibody in PBS-1% BSA, washed
5 times and then labelled with 10 nm protein A-gold particles in PBS-
1% BSA for 20 min. Sections were ﬁnally washed 10 times in PBS,
ﬁxed for 5 min with 1% gluteraldehyde in PBS, rinsed in distilled
water and incubated for 5 min with uranyl oxalate solution. Grids
were then rinsed in distilled water, incubated with 2% methyl
cellulose (Sigma-Aldrich) and 0.4% uranyl acetate for 5 min on ice
and then dried at room temperature. Samples were analysed with a
Zeiss 912 electron microscope and images were then processed using
Adobe Photoshop 7.0.
Cytotoxicity and cell viability assays. Measurement of lactate
dehydrogenase (LDH) release in the supernatant of cells infected with
different strains was carried out using the Detection Kit (Roche) as
indicated by the manufacturer. The percentage of cytotoxicity
corresponds to the ratio between the experimental value subtracted
by the negative control (spontaneous LDH release) and the maximum
LDH release (triton lysed cells) subtracted by the negative control.
For detection of 7-AAD, cells were infected with GFP-expressing
strains as described above and collected at 24 h in cold PBS. Cells
were then labelled ﬁrst for CD11c-APC, washed several times in cold
PBS and then incubated with 7-AAD following the manufacturer’s
instructions (BD Pharmingen). The ﬂow cytometric analysis were
performed on ﬁxed cells within 20 min.
Cytokine measurement. Sandwich enzyme-linked immunosorbent
assays (ELISA) from Abcys were used to detect IL-12 (p40/p70), TNFa
and IL-6 from supernatants of BMDCs infected with different Brucella
strains. The ELISA kit for IFNb measurement was obtained from PBL
Biomedical Laboratories.
Antigen presentation assay. DCs were seeded at 1 3 10
5 cells per
well in 96-well ﬂat bottom plates and infected for 30 min as described
above. Cells were then washed and ovabulmin (Sigma-Aldrich) was
added at a ﬁnal concentration of 50 lg/ml for 2 h in media containing
100 lg/ml of streptomycin to kill extracellular bacteria. Antigen was
then removed by changing media and DCs were co-cultured with
splenic CD4
þ T cells prepared from OTI and OTII transgenic mice
(added at a 1:1 ratio) for a remaining 48 h in media containing 20 lg/
ml of streptomycin. Supernantants were then collected and IL-2
production was assessed by evaluating the growth of IL-2-dependent
CTLL-2 cell line (10
4 cells/well) after 24 h and incorporation of
3H-
thymidine (NEN, 0.5 lCi per well) during 8 h of incubation. All
experiments were done in triplicates and the data presented
corresponds to a representative experiment of three independent
repeats. Data are expressed as the arithmetic mean counts per
minute. Brucella did not induce cytotoxicity of DCs (Figure S2) and
did not affect uptake of ﬂuorescently labelled OVA (data not shown).
Luciferase activity assay. HEK 293T cells were transiently
tranfected using Fugene (Roche) for 24 h, according to manufac-
turer’s instructions, for a total of 0.4 lg of DNA consisting of 50 ng
TLR plasmids, 200 ng of pBIIXLuc reporter plasmid, 5 ng of control
Renilla luciferase (pRL-null, Promega) and indicated amounts of Btp
expression vectors. The total amount of DNA was kept constant by
adding empty vector. Were indicated, cells were treated with E. coli
LPS (1 lg/ml), Pam2CSK4 (1 ng/ll) or CpG ODN1826 (10 lM) for 6 h
and then cells were lysed and luciferase activity measured using Dual-
Glo Luciferase Assay System (Promega). The TLR2 construct was
obtained by PCR ampliﬁcation from cDNA of bone marrow-derived
macrophages and subcloning in the pCDNA3.1 expression vector
(Promega).
Statistical analysis. All experiments were carried out at least 3
independent times and all the results correspond to the means 6
standard errors. Statistical analysis was done using two-tailed
unpaired Student’s t test and p   0.05 were not considered signiﬁcant.
Supporting Information
Figure S1. Analysis of DC Viability during Infection
(A) BMDCs were infected with either S. typhimurium, B. abortus wild-
type, or btp1 mutant strains and the supernatants collected at 24 or 48
h for detection of lactate dehydrogenase (LDH) activity. Staurosporin
was used as a positive control at a ﬁnal concentration of 200 nM.
Results correspond to percentage cytotoxicity in relation to the
negative and maximum values of LDH release and were obtained
from three independent experiments. (B and C) DCs were infected
with either S. typhimurium or B. abortus wild-type strains expressing
GFP and analysed by ﬂow cytometry for labelling with the vital dye 7-
Amino-actinomycin (7-AAD). Results correspond to CD11c-positive
(B) or CD11c GFP-positive (C) cells. The percentage of cells that are
7AAD-positive are indicated in each histogram.
Found at doi:10.1371/journal.ppat.0040021.sg001 (543 KB TIF).
Figure S2. Confocal Microscopy Analysis of MHC II Labelling in Bone
Marrow-derived DCs and Macrophages
(A) Cells were labelled with anti-MHC II (rivoli, red) and anti-CD11c
(blue) antibodies and, in the case of Brucella (wt) with anti-LPS
antibody (green). All cells showing signiﬁcant MHC II labelling were
CD11c-positive.
(B) Control labelling of bone marrow-derived macrophages infected
with B. abortus stained with the anti-MHC II antibody (red). No
signiﬁcant labelling was observed in macrophages whereas some small
DALIS (labelled with the FK2 antibody, blue) were occasionally
observed.
Found at doi:10.1371/journal.ppat.0040021.sg002 (2.1 MB TIF).
Figure S3. B. abortus Fails to Replicate in Mature DCs
Intracellular CFUs were enumerated by lysing cells at 2, 24, or 48 h
after infection of DCs with wild-type B. abortus, in absence (black) or
presence of E. coli LPS (100 ng/ml). E. coli LPS was added at either 30
min (red), 2 h (yellow), 6 h (grey), or 12 h (white) after infection. Each
infection was carried out in triplicate and values correspond to
means 6 standard errors. There is a statistical difference between B.
abortus (48 h) and B. abortus þ LPS added at 12 h (p ¼ 0.002) and also
added at 30 min, 2, and 6 h (p , 0.001). The values are representative
of three independent experiments.
Found at doi:10.1371/journal.ppat.0040021.sg003 (115 KB TIF).
Figure S4. The btp1 Mutant Does Not Differ from Wild-type Brucella
with regard to Expression of Co-stimulatory Molecules
DCs were either incubated with media only (blue line) or infected
with B. abortus wild-type (shaded grey) or btp1 mutant (red line)
expressing GFP for 24 h. DCs were labelled with anti-CD11c
conjugated with APC and anti-CD40, CD80, CD86, and MHC II
antibodies conjugated with PE. Representative histograms showing
the PE ﬂuorescence (FL2) correspond to CD11c
þcells for the negative
and CD11c
þ GFP
þ cells for the Brucella infected cells.
Found at doi:10.1371/journal.ppat.0040021.sg004 (232 KB TIF).
Figure S5. Analysis of the Effect of LPS Extracts on DC Maturation
and Complementation of btp1 Mutant
(A and B) DCs were incubated for 24 h with crude LPS extracts from
either wild-type B. abortus, the btp1 mutant, or S. typhimurium. Samples
were then labelled with the FK2 antibody (red), anti-CD11c (blue),
and either anti-Brucella LPS or Salmonella-LPS antibodies. DALIS are
indicated by arrows. (A) corresponds to means 6 standard errors of 3
independent experiments.
(C) Analysis of TNF-a and IL-12 (p40/p70) secretion measured by
ELISA from the supernatant of DCs 24 and 48 h after inoculation
with wild-type (wt), btp1
 ,o rbtp1
 pbtp1. The results correspond to a
representative of two independent experiments.
Found at doi:10.1371/journal.ppat.0040021.sg005 (1.0 MB TIF).
Figure S6. Analysis of the Formation of DALIS in Different Knockout
Mice
BMDCs obtained from wild-type mice or different knockout mice
were treated with the appropriate ligand for 24 h. The percentage of
cells containing DALIS was then quantiﬁed by immunoﬂuorescence
microscopy. A representative from three independent experiments is
shown.
Found at doi:10.1371/journal.ppat.0040021.sg006 (197 KB TIF).
Figure S7. Heat-Killed Brucella Induction of DALIS Is Dependent on
Myd88 and TLR2
DCs were incubated for 24 h with either the TLR2 ligand PAM (500
ng/ll) or heat-killed Brucella (HK). Samples were then labelled with
the FK2 antibody (red) and anti-MHC II (green).
(A) Quantiﬁcation corresponds to means 6 standard deviations of
two independent experiments.
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Figure S8. Analysis of the Formation of DALIS in the Presence of LPS
and PAM
DCs were infected for 24 h with wild-type B. abortus and either
incubated for a further 24 h with or without E. coli LPS or PAM.
Samples were then labelled with the FK2 antibody (red) antibody.
(A) Non-infected cells treated with E. coli LPS for 24 h.
(B) Wild-type Brucella gfp-infected cells at 48 h post-infection.
(C) wild-type Brucella gfp-infected cells (24 h post-infection) further
treated with E. coli LPS for another 24 h.
(D) wild-type Brucella gfp-infected cells (24 h post-infection) further
treated with PAM for another 24 h (see on the same coverslip the
upper infected cell displaying a much less maturation pattern than
the lower cell that has not been infected).
Found at doi:10.1371/journal.ppat.0040021.sg008 (376 KB TIF).
Accession Numbers
The Entrez Protein (http://www.ncbi.nlm.nih.gov/sites/entrez?db¼protein)
accession number for Btp1 (BAB1_0279) is GI: 82699179.
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